Karyopharm Therapeutics (KPTI) Fails to deliver data

Key failure to deliver metrics for Karyopharm Therapeutics :

• Last SEC data release: 2026-02-13
• Last 15 days FTD volume: NZ$0.08 M
• Last 3 months FTD volume: NZ$0.18 M
• Last 12 months FTD volume: NZ$10.38 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Karyopharm Therapeutics (KPTI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Karyopharm Therapeutics (KPTI) - since 2025

Karyopharm Therapeutics (KPTI) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Abbott Laboratories ABT	NZ$9.81 M	NZ$0.26 B	🇺🇸 USA
Merck MRK	NZ$0.11 B	NZ$0.20 B	🇺🇸 USA
Bristol-Myers Squibb BMY	NZ$40.01 M	NZ$94.16 M	🇺🇸 USA
Exelixis EXEL	NZ$20.34 M	NZ$31.53 M	🇺🇸 USA